Drug class
Diazabicyclooctane (DBO) beta-lactamase inhibitor; component of sulbactam/durlobactam combination
Mechanism of action
Inhibits class A, C and D serine beta-lactamases, including OXA-type enzymes produced by Acinetobacter baumannii, protecting sulbactam from enzymatic hydrolysis. It has little intrinsic antibacterial activity and is administered with sulbactam.
General use cases
- Component of the fixed combination sulbactam/durlobactam for treatment of hospital-acquired and ventilator-associated bacterial pneumonia caused by susceptible Acinetobacter baumannii-calcoaceticus complex in adults; not a standalone antibacterial indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
